UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

NeuroSigma, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   26-3105690
(State of incorporation or organization)   (I.R.S. Employer Identification No.)
10960 Wilshire Boulevard, Suite 1910, Los Angeles, California   90024
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Common Stock, $0.0001 par value   The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ¨

Securities Act registration statement file number to which this form relates: 333-198374 (if applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

None

(title of class)

 

 

 


Item 1. Description of Registrant’s Securities to be Registered.

A description of the shares of common stock, par value $0.0001 per share, of NeuroSigma, Inc. (the “Company”) being registered hereunder is set forth under the caption entitled “Description of Capital Stock” in the Company’s Registration Statement on Form S-1 (File No. 333-198374), as initially filed with the Securities and Exchange Commission on August 26, 2014, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement to be filed separately by the Company with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits.

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Company are to be registered on The NASDAQ Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

    NEUROSIGMA, INC.
Date: October 6, 2014     By:  

/s/ Leon Ekchian

    Name:   Leon Ekchian
    Title:   President and Chief Executive Officer
NEUROSIGMA, INC. (NASDAQ:NSIG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more NEUROSIGMA, INC. Charts.
NEUROSIGMA, INC. (NASDAQ:NSIG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more NEUROSIGMA, INC. Charts.